ITNS (Itonis) Total Payout Ratio: 0.61 (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Itonis Total Payout Ratio?

Itonis ITNS Total Payout Ratio is 0.61 as of Sep. 07, 2026.

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Itonis's current Total Payout Ratio is 0.61.

Itonis Total Payout Ratio Related Terms

Itonis Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for Itonis's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Itonis Total Payout Ratio Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
Total Payout Ratio
0.21 0.12 0.52

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.23 0.97 0.47 0.90

ITNS vs FZMD, SNYR, SGMFF: Total Payout Ratio Comparison

For the Medical Distribution subindustry, Itonis's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Itonis Total Payout Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Itonis's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Itonis's Total Payout Ratio falls into.


Itonis Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Itonis's Total Payout Ratio for the fiscal year that ended in Nov. 2007 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0.725 + 0) / -1.398
=0.52

Itonis's Total Payout Ratio for the quarter that ended in Feb. 2008 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0.375 + 0) / -0.417
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Ratio →
What does a Total Payout Ratio of 0.61 mean?
Itonis (ITNS) has a Total Payout Ratio of 0.61 as of Sep. 07, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Itonis and its competitors.
Is Itonis' Total Payout Ratio too high?
Itonis' current Total Payout Ratio is 0.61.
How does Itonis' Total Payout Ratio compare to FZMD and SNYR?
Itonis' Total Payout Ratio of 0.61 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for a Medical Distribution company?
A good Total Payout Ratio depends on the Medical Distribution industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Itonis and its competitors. Itonis's current Total Payout Ratio is 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Itonis stock overvalued right now?
Itonis (ITNS) has a current Total Payout Ratio of 0.61. The current Total Payout Ratio is 0.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For Itonis (ITNS), the current Total Payout Ratio is 0.61 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Itonis Business Description

Address 25422 Trabuco Road, Suite 105-297, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.